Each of the 12 subjects will participate in two blinded experimental sessions, assisted by either MDMA or placebo lasting seven hours within a brief course of non-drug therapy. The non-drug therapy includes three hour-long preparatory sessions at the start of the study and three hour-long integrative sessions during the month after each experimental session at two week intervals.